AVICANNA INC (AVCN.CA) Stock Price, Forecast & Analysis
Canada - Toronto Stock Exchange - TSX:AVCN - CA05368K1003 - Common Stock
AVCN.CA Key Statistics, Chart & Performance
The current stock price of AVCN.CA is 0.225 CAD. In the past month the price decreased by -15.09%. In the past year, price decreased by -36.62%.
AVCN.CA Latest News, Press Relases and Analysis
AVCN.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| BHC.CA | BAUSCH HEALTH COS INC | 1.63 | 3.24B | ||
| TLRY.CA | TILRAY BRANDS INC | N/A | 1.65B | ||
| CRON.CA | CRONOS GROUP INC | 23.2 | 1.33B | ||
| DHT-UN.CA | DRI HEALTHCARE TRUST | 7.32 | 908.43M | ||
| DHT-U.CA | DRI HEALTHCARE TRUST | 5.14 | 637.07M | ||
| GUD.CA | KNIGHT THERAPEUTICS INC | N/A | 600.70M | ||
| WEED.CA | CANOPY GROWTH CORP | N/A | 575.02M | ||
| NGEN.CA | NERVGEN PHARMA CORP | N/A | 401.55M | ||
| CPH.CA | CIPHER PHARMACEUTICALS INC | 15.89 | 374.23M | ||
| ACB.CA | AURORA CANNABIS INC | N/A | 364.58M | ||
| HITI.CA | HIGH TIDE INC | N/A | 322.75M | ||
| OGI.CA | ORGANIGRAM GLOBAL INC | N/A | 302.24M |
Related stock screener links
About AVCN.CA
Company Profile
Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-07-18. The company focuses on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Its products and services are grouped into four main categories, such as medical cannabis products; MyMedi.ca medical cannabis platform; pharmaceutical pipeline; and active pharmaceutical ingredients. The formulary of proprietary medical cannabis products is marketed under the RHO Phyto brand and offers a range of scientifically driven formulations in a variety of products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca offers a diverse portfolio of products and bilingual pharmacist-led patient support programs. The company has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. Trunerox is its oral formulation.
Company Info
AVICANNA INC
480 University Avenue, Suite 1502
TORONTO ONTARIO M5G 1V2 CA
CEO: Aras Azadian
Employees: 38
Phone: 16472435283
AVICANNA INC / AVCN.CA FAQ
What does AVICANNA INC do?
Avicanna, Inc. is a medical cannabis company, which intends to engage in the business of discovery and development processes, intellectual property portfolio, strategic relationships, and cultivation infrastructure. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-07-18. The company focuses on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Its products and services are grouped into four main categories, such as medical cannabis products; MyMedi.ca medical cannabis platform; pharmaceutical pipeline; and active pharmaceutical ingredients. The formulary of proprietary medical cannabis products is marketed under the RHO Phyto brand and offers a range of scientifically driven formulations in a variety of products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca offers a diverse portfolio of products and bilingual pharmacist-led patient support programs. The company has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. Trunerox is its oral formulation.
What is the stock price of AVICANNA INC today?
The current stock price of AVCN.CA is 0.225 CAD. The price decreased by -4.26% in the last trading session.
Does AVICANNA INC pay dividends?
AVCN.CA does not pay a dividend.
What is the ChartMill technical and fundamental rating of AVCN stock?
AVCN.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Can you provide the number of employees for AVICANNA INC?
AVICANNA INC (AVCN.CA) currently has 38 employees.
AVCN.CA Technical Analysis
AVCN.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AVCN.CA. While AVCN.CA seems to be doing ok healthwise, there are quite some concerns on its profitability.
AVCN.CA Financial Highlights
Over the last trailing twelve months AVCN.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS increased by 85.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -6.26% | ||
| ROE | -50.28% | ||
| Debt/Equity | 0 |